Ensysce Biosciences, Inc (ENSC) Social Stream
ENSYSCE BIOSCIENCES INC (ENSC) Price Targets From Analysts
Use the tables below to see what analysts covering ENSYSCE BIOSCIENCES INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-30 | 1 | $4 | $4 | $4 | $1.15 | 247.83% |
| 2022-04-06 | 1 | $23 | $4 | $13.5 | $1.15 | 1073.91% |
| 2022-05-17 | 1 | $11 | $4 | $7.5 | $1.15 | 552.17% |
| 2022-10-25 | 1 | $12 | $4 | $8 | $1.15 | 595.65% |
| 2022-11-16 | 1 | $240 | $80 | $160 | $1.15 | 13813.04% |
| 2022-11-17 | 1 | $240 | $8 | $124 | $1.15 | 10682.61% |
| 2022-12-08 | 1 | $8 | $5.3 | $6.65 | $1.15 | 478.26% |
| 2023-02-07 | 1 | $96.038 | $43.817 | $69.927 | $1.15 | 5980.61% |
| 2023-04-03 | 1 | $96.038 | $43.8 | $69.919 | $1.15 | 5979.91% |
| 2023-04-12 | 1 | $43.8 | $15 | $29.4 | $1.15 | 2456.52% |
| 2023-05-09 | 1 | $17.25 | $15 | $16.125 | $1.15 | 1302.17% |
| 2023-05-16 | 1 | $17.85 | $15 | $16.425 | $1.15 | 1328.26% |
| 2023-08-11 | 2 | $17.85 | $9 | $13.95 | $1.15 | 1113.04% |
| 2023-09-25 | 2 | $17.85 | $7 | $13.283 | $1.15 | 1055.04% |
| 2023-11-10 | 2 | $17.5 | $7 | $13.166 | $1.15 | 1044.87% |
| NA | 1 | $NA | $NA | $NA | $1.15 | NA% |
The Trend in the Analyst Price Target
ENSC's average price target has moved down $3.26 over the prior 178 days.
ENSC reports an average of 1,496.43% for its upside potential over the past 39 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-04-03 | 1 | 96.038 | 43.8 | 69.919 | 4.70 | 1387.64% |
| 2023-05-16 | 2 | 17.850 | 15.0 | 16.425 | 2.97 | 453.03% |
| 2023-08-08 | 2 | 17.850 | 9.0 | 13.950 | 1.89 | 638.1% |
| 2023-08-11 | 2 | 17.850 | 9.0 | 13.950 | 1.90 | 634.21% |
| 2023-09-25 | 2 | 17.850 | 7.0 | 13.283 | 1.45 | 816.07% |
ENSC Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 2 | 0 | 0 | 0 | 0 | 2 |
The Trend in the Broker Recommendations
ENSC's average broker recommendation rating improved by 0 over the prior 48 weeks.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ENSC as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, ENSYSCE BIOSCIENCES INC's number of analysts covering the stock is greater than 11.32% of them.
- In terms of how ENSYSCE BIOSCIENCES INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 1647.77% of that group.
- ENSYSCE BIOSCIENCES INC's variance in analysts' estimates is lower than -985.7% of stocks in the small market cap category.
- To contextualize these metrics, consider that out of Healthcare stocks, ENSYSCE BIOSCIENCES INC's average analyst price target is greater than 589.06% of them.
Stocks similar to ENSYSCE BIOSCIENCES INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are NRXP, NCNA, and ATNF.
View All Top Stocks by Price Target
Make investment decisions regarding ENSC using the data that counts. Try POWR Ratings for free.